Company faces severe financial distress with 16% revenue decline, negative free cash flow (-$157M), $500M debt burden, Nasdaq delisting risk, high customer concentration (13% from one customer), and persistent losses. While attempting a turnaround with new beverage products, execution remains unproven.
Declining revenue (16% YoY drop to $275.5M), negative free cash flow of -$157M, substantial debt of $500M, projected 2026 losses of $244M with only $245M in expected sales, persistent consumer demand weakness, and heavy reliance on turnaround strategy through beverage expansion that remains unproven.
Declining revenue (-15.6% YoY), negative free cash flow (-$172.8M), shareholder deficit, company in restructuring with layoffs and market exits, stock trading near delisting territory, and struggling to maintain consumer demand in a competitive market indicate significant challenges.
The company faces severe headwinds including a 99.6% five-year stock decline, 40% revenue drop since 2021, continued operating losses, weak Q1 2026 results, and management's risky product expansion strategy from a position of weakness. The analyst explicitly recommends avoiding the stock.
Stock rallied on news of new product launch at major retailers (Wegmans and H-E-B) with positive customer feedback. The Beyond Steak Filet is the top-selling product on their e-commerce platform, and the company is diversifying into functional beverages. However, this positive momentum is tempered by the company's ongoing revenue decline of 15% year-over-year.
The company successfully launched a new flagship product that became the #1 seller on its DTC platform and is now expanding to major retail chains (Wegmans and H-E-B). CEO Ethan Brown expressed strong confidence in the product as their most compelling innovation since Beyond Burger. The product has strong nutritional credentials and positive consumer feedback, indicating successful market traction and growth potential.
Company reported 15% revenue decline year-over-year, missed analyst estimates on both revenue and earnings, experienced nearly 20% volume decline across all sales channels, and faces intense competition in crowded alt-meat and beverage markets. Stock fell 20% in May despite new product launch.
Stock has lost 99% of its value; 2025 revenue fell 16% with operating losses of $333 million; Q1 2026 revenue declined 15% year-over-year; protein drink pivot is limited-time only and shows no early financial improvements; company faces intense competition from established beverage giants.
The company faces severe operational challenges including 15.3% year-over-year sales decline, minimal 3.4% gross margin, and negative 70.6% operating margin. While the protein drink strategy shows promise, it remains highly speculative in a saturated market. The stock has declined 99% over five years, and success is uncertain despite the Big Geyser distribution partnership.
Stock down 97% from IPO, trading under $1, sales declining 15% YoY, negative operating margin of -70.6%, declining sales across all segments (retail, foodservice, international), and gross margin compressed to 3.4%. Despite new product launches, fundamental business metrics remain weak.
Stock declined 9.13% following earnings. While EPS met expectations, revenue declined year-over-year and most business segments showed weakness, particularly U.S. retail (-15.3%) and foodservice (-29.7%). Forward guidance of $60-65 million for Q2 missed analyst estimates of $66.97 million, indicating continued challenges ahead.
Stock has collapsed 96% since IPO; revenue declining consistently (down 16% in 2025, expected 9% decline in 2026); gross margin compressed from 33.5% to 2.8%; facing operational losses of $163M expected in 2026; lost pricing power and market share to competitors; failed joint venture with PepsiCo; share dilution of 695% since IPO.
Despite the intraday rally, the stock is trading near its 52-week low of $0.50, down 60.32% over the past year. Analyst sentiment remains bearish with BMO Capital and Barclays both downgrading price targets. The company missed Q4 2025 EPS estimates significantly (163.64% miss), and upcoming Q1 earnings are expected to show continued losses. The technical recovery appears to be a short-term bounce rather than a fundamental improvement.
While the stock is experiencing short-term meme-stock momentum with a 40% monthly gain, the underlying business fundamentals are deteriorating significantly. The company reported worse-than-expected losses, declining sales (down 19.7% YoY), minimal gross margins (2.3%), and guidance for further sequential declines. The article explicitly states the stock 'remains very risky' and gains are driven by speculation rather than business improvement.
The company reported deteriorating fundamentals including 20% revenue decline, massive operating loss of $133.6 million (vs. $37.8 million prior year), and guidance for further revenue declines in Q1 2026. The recent 40% stock surge appears driven by speculation rather than business improvement, with the stock already giving back gains. The company has lost 99% of its value over five years, indicating persistent structural challenges.
Despite this week's 6.1% gain, the company faces severe structural challenges including declining sales, critically low 2.68% gross margins, and a devastating 99% stock decline over five years. The weekly surge is attributed to external factors (market momentum and meme-stock trading) rather than company fundamentals. Management's turnaround efforts with new drink lines remain speculative and uncertain.
The company is expanding its product portfolio with a new flavor variant achieving Clean Label Project certification, demonstrating continued innovation and market penetration through nationwide distribution at major retailers like Kroger. The expansion of their chicken product line and achievement of certifications indicate business growth and consumer acceptance.
Company faces severe financial distress with stock in penny-stock territory and delisting risk. Despite strategic pivot to protein market being sound, the company has never achieved profitability, sales are declining since 2022, and it's attempting to compete against much larger, established competitors from a position of weakness.
Experiencing enormous trading volume (259M shares vs 38M average) with 33.7% short float, but shares are slightly lower at $1.13, indicating mixed momentum despite high activity
Stock gained 18.50% on Friday driven by a strategic partnership with Big Geyser that significantly expands distribution channels from direct-to-consumer to over 26,000 retail outlets in New York. Technical indicators show bullish momentum with MACD above signal line and RSI at 60.87, supporting near-term price strength despite longer-term bearish trends and a Sell rating from analysts.
The company faces imminent delisting risk, declining core business (Q4 revenue down 20% YoY), extremely low stock price ($0.66), poor gross margins (10.3% vs 30% target), and a desperate rebranding pivot away from its core identity. The analyst explicitly states this is 'not a turnaround story, but a company running out of viable options' with high execution risk and unfavorable market conditions.
The company is expanding its product portfolio with a new breakfast sausage line featuring improved ingredients (avocado oil), achieving Clean Label Project Certification, and securing distribution at major national retailers (Kroger, Sprouts, Whole Foods). This represents product innovation, market expansion, and third-party validation of product quality.
The company missed two consecutive earnings release dates, reported a 15.6% revenue decline with 15.9% volume drop across all divisions, took massive one-time charges for the second quarter in a row, and faces unclear prospects for its rebranding strategy. The persistent contraction in its core meat alternative business and weakened operational position following restructuring efforts indicate serious fundamental challenges.
Company faces multiple severe headwinds including 20% YoY revenue decline, product pricing at 2x traditional meat, weak volume sales (down 22%), negative GAAP earnings of -$0.29 per share, bearish analyst sentiment (Strong Sell rating), high short interest near 30%, and profitability not expected until early 2030s. Additional risk of delisting if stock fails to maintain $1+ price for 10 consecutive days. Only modest hope from protein drink market opportunity.
Company faces multiple severe headwinds: 24% stock decline in March, material weaknesses in financial controls, inventory accounting errors, double-digit revenue declines (19.7% in Q4), widening losses (EBITDA loss expanded from $26M to $69M), stock price below $1, and negative Q1 2026 guidance (-15% revenue). Delayed 10-K filing adds regulatory concerns.
Company reported Q4 earnings and sales significantly below analyst expectations, posted a larger-than-expected loss per share, experienced 20% year-over-year sales decline, issued disappointing forward guidance below consensus estimates, and faces potential delisting risk requiring a reverse stock split due to stock price falling below $1.
Dropped 10.21% after missing earnings estimates with full-year revenue of $275.5 million, down 15.6% year-over-year. Weak price trends across all timeframes.
The company has experienced a 99.7% stock price decline since 2021, faces delisting risk, has declining revenues (from $464.7M in 2021 to projected $275.9M in 2025), massive operating losses in the nine-digit range, and severe shareholder dilution. A reverse stock split would be cosmetic and fail to address fundamental problems. The article describes the situation as a 'dilution death spiral' with no improvement in sight.
The company faces severe financial challenges including an 84% decline from 52-week highs, stock price below $0.70 (below the $1 Nasdaq minimum), deteriorating sales, low gross margins (5.98%), substantial operating losses, and delayed annual filings. The article indicates a likely forced reverse stock split and risk of delisting, which would further pressure the stock and limit fundraising options.
The company delayed its annual report filing for the second time, citing material weaknesses in internal controls related to inventory that may have led to errors in previously issued financial statements. The stock is trading near 52-week lows, down 79.51% over 12 months, with bearish technical indicators (trading below 20-day and 50-day SMAs, negative MACD). These governance and operational issues, combined with weak technical performance, indicate significant negative sentiment.
Company faces shareholder class action lawsuit alleging false/misleading statements about book value of long-lived assets, suggesting potential accounting fraud or asset impairment issues.
The company is the subject of a securities class action lawsuit alleging material misstatements and omissions regarding asset valuations and impairment charges, which resulted in investor damages when the true details became public.
The company is the subject of a securities fraud class action lawsuit alleging material misstatements and omissions regarding asset valuations and financial reporting capabilities, which directly harms investor interests and indicates serious corporate governance and accounting issues.
The company faces declining consumer demand, persistent losses, inventory spoilage issues, and delayed earnings reporting. While the freezer relocation may stabilize the business, it represents a retreat from mainstream appeal and signals lower but more reliable revenues at reduced scale.
The company is the subject of a securities class action lawsuit alleging material misstatements and omissions regarding asset impairment charges and SEC filing delays, indicating significant corporate governance and financial reporting issues that resulted in investor losses.
The company achieved a significant milestone by becoming the first plant-based meat company to earn Clean Label Project Certification for 20+ products, demonstrating commitment to quality, transparency, and rigorous safety standards. This external validation strengthens brand credibility and market positioning.
The company is facing multiple serious issues: delayed annual report due to inventory accounting problems and material weakness in internal controls, Nasdaq deficiency warning with stock price below $1, declining revenue and market cap shrunk to under $350 million (less than 10% of IPO valuation), and broader sector headwinds including negative consumer perception of plant-based products as ultra-processed and expensive compared to alternatives.
The company delayed its annual report filing due to inventory review issues, creating uncertainty about potential financial statement impacts. Shares fell 8.66% on the news, and the stock has declined 78.24% over the past 12 months, trading near 52-week lows. While preliminary revenue met guidance, the delay and inventory concerns signal operational challenges.
The company is the subject of a securities class action lawsuit alleging material misstatements regarding asset valuations and impairment charges, which resulted in investor damages when the true details entered the market.
The company is the subject of a securities class action lawsuit alleging material false and misleading statements regarding asset valuations and impairment charges that would impact SEC filing compliance. This indicates significant financial and operational issues that harmed investors.
Articles that tag BYND but are mainly about other companies.
Beyond Meat's first-quarter revenue fell 15.3% year-over-year to $58.2 million due to weak demand and reduced distribution in certain channels, indicating consumer pressure on discretionary food products.
Included as a key player in the market with strong positioning in the growing plant-based protein snacks segment, a major trend driving market expansion.
Plunged 11% after reporting in-line Q1 loss and guiding Q2 revenue below analyst estimates. Weak long-term price trend despite strong short/medium-term trends.
Subject of shareholder class action lawsuit with lead plaintiff deadline announced, indicating alleged corporate misconduct.
Company is subject to securities class action lawsuit with an approaching March 24 deadline, indicating alleged securities violations.
Company is subject to securities class action lawsuit with an approaching March 24 deadline, indicating alleged securities violations and investor claims.
Stock down 98% from 2019 IPO despite initial surge, exemplifying IPO risks and post-IPO volatility.
Articles and sentiment ratings from Massive / Polygon. Sentiment is the provider's model rating for this company, not Gainbot's view.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology
